GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?
- PMID: 25455093
- DOI: 10.1053/j.ajkd.2014.10.002
GFR decline as an alternative end point in clinical trials to prevent ESRD: are we increasing treatment uncertainty for the sake of feasibility?
Comment on
-
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.Am J Kidney Dis. 2014 Dec;64(6):848-59. doi: 10.1053/j.ajkd.2014.08.017. Epub 2014 Oct 16. Am J Kidney Dis. 2014. PMID: 25441438
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
